Avalyn Pharma Inc.
Ownership
Ownership Structure
Who owns Avalyn Pharma Inc. (AVLN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 61.8% of the shares are freely tradable; institutional investors hold 66.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 7.46 | 3,308,649 | +0.0 | 06/30/2026 |
| Perceptive Advisors LLC | 6.03 | 2,675,296 | +0.0 | 06/30/2026 |
| NVP Associates LLC | 5.12 | 2,268,404 | +0.0 | 06/30/2026 |
| Wellington Management Company LLP | 4.97 | 2,201,986 | +0.0 | 06/30/2026 |
| Catalio Capital Management, LP | 3.78 | 1,675,830 | +0.0 | 06/30/2026 |
| Eventide Asset Management, LLC | 3.10 | 1,375,486 | +0.0 | 06/30/2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | 2.18 | 966,792 | +0.0 | 06/30/2026 |
| Citadel Advisors Llc | 2.16 | 959,098 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 3.10 | 1,375,486 | -93.3 | 06/30/2026 |
| Fidelity Small Cap Growth | 2.78 | 1,231,620 | +1.2 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.